Tilray IncTLRY
± MixedCapitalrelevance
Earnings report could beat expectations and trigger rally, but company has history of large losses and stock is near 52-week low.
Impact on stocks 1
Health Care
Tilray IncTilray Brands is scheduled to report its fourth-quarter and full fiscal year 2026 results on July 28, with investors watching for continued revenue growth improvement and a reduction in massive annual losses. The Canadian cannabis producer’s quarterly year-over-year revenue growth has recently returned to double digits, but the company has posted annual losses exceeding $1 billion in two of the past three fiscal years due to non-cash expenses and impairment charges. Tilray’s stock has fallen 97% over the past five years and is trading near its 52-week low, making the upcoming report a potential catalyst for a rally if results beat expectations. However, the article cautions that a wait-and-see approach may be prudent given the company’s track record and ongoing uncertainty.
Tilray IncEarnings report could beat expectations and trigger rally, but company has history of large losses and stock is near 52-week low.